Page last updated: 2024-10-28

ha14-1 and Lymphoma

ha14-1 has been researched along with Lymphoma in 2 studies

ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research Excerpts

ExcerptRelevanceReference
" Importantly, low-concentration HA14-1 (5 muM) was nontoxic to normal colony-forming cells, whereas it enhanced the cytotoxicity of the antileukemia drug cytarabine in Bcl-2-positive lymphoblastic leukemia cells."7.72HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. ( Cox, J; Johnson, L; Lickliter, JD; McHugh, G; Tan, J; Wickham, NW; Wood, F; Wood, NJ, 2003)
" Importantly, low-concentration HA14-1 (5 muM) was nontoxic to normal colony-forming cells, whereas it enhanced the cytotoxicity of the antileukemia drug cytarabine in Bcl-2-positive lymphoblastic leukemia cells."3.72HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. ( Cox, J; Johnson, L; Lickliter, JD; McHugh, G; Tan, J; Wickham, NW; Wood, F; Wood, NJ, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lickliter, JD2
Wood, NJ1
Johnson, L1
McHugh, G1
Tan, J1
Wood, F1
Cox, J2
Wickham, NW1
McCarron, J1
Martinez, NR1
Schmidt, CW1
Lin, H1
Nieda, M1
Nicol, AJ1

Other Studies

2 other studies available for ha14-1 and Lymphoma

ArticleYear
HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death.
    Leukemia, 2003, Volume: 17, Issue:11

    Topics: Apoptosis; Benzopyrans; Blast Crisis; Bone Marrow Cells; Cell Death; Cell Survival; Cytarabine; Drug

2003
Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.
    British journal of cancer, 2007, Feb-26, Volume: 96, Issue:4

    Topics: Adult; Antineoplastic Agents; Benzopyrans; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation;

2007